www.pharmaandlifesciences.com Open in urlscan Pro
92.51.243.170  Public Scan

Form analysis
1 forms found in the DOM

GET https://www.pharmaandlifesciences.com/

<form method="get" id="searchform" class="form-search center-text" action="https://www.pharmaandlifesciences.com/">
  <label for="s" class="cfc-h-tx tt-upper">Type and Press “enter” to Search</label>
  <input type="text" id="s" class="search-query cfc-h-tx center-text tt-upper" name="s">
</form>

Text Content

The National Pharmaceutical and Life Sciences Expo
May 25th-26th 2022
RDS Simmonscourt, Dublin


Register Free
Contact us

Navigation
 * Home
 * Agenda
 * Speakers
 * Associations
 * Exhibitors
 * Sponsors
 * Media
   * Partners
 * Register
 * Contact
 * Search

 * Home
 * Agenda
 * Speakers
 * Associations
 * Exhibitors
 * Sponsors
 * Media
   
   * Partners
 * Register
 * Contact
 * Search

Pharmaceutical and Life Sciences
25th-26th May 2022 | RDS Simmonscourt, Dublin
REGISTER NOW

--------------------------------------------------------------------------------

Pharmaceutical and Life Sciences is being held in the RDS Simmonscourt, Dublin
on 25th-26th May 2022
This gathering of over 1000 senior management from the pharmaceutical and
life-sciences sector offers an opportunity for the pharma and life science
sector to gather and keep up to date with the latest innovations, best practice
and new technology solutions

Over 30 speakers and 50 exhibitors will inform and educate and inform the
delegates who have network and listen to key note talks.

Sectors Attending

– Pharma
– Biotech,
– Med-tech
– Diagnostics
– Animal health

Why Attend

– Educational seminars on the latest industry issues
– Key insights from industry thought leaders & service providers
– First-hand case studies from leading Irish and global pharmaceutical and life
science companies
– Hands-on demonstrations of the latest solutions in the technology showcase
– Excellent networking opportunities with peers throughout the day
– Meet over 50 exhibitors that can meet your needs

Who Visits

– Manufacturing director
– Plant manager
– R&D Director
– NPD director
– Warehouse Manager
– Facility manager
– Production head
– Procurement Directors
– Engineering Director
– Technical Director
– Energy Manager
– Sustainability director
– Scientists
– Data Analysts

SPEAKERS CONFIRMED

JAMES LARDNER

PRINCIPAL SOFTWARE ENGINEER - BOSTON SCIENTIFIC

"CONNECTED FACTORY AND MANUFACTURING DATA EXTRACTION"

Speaker Bio Synopsis



James has a B.Sc in Mathematical Science and Computer Studies and has over 20
years of experience working in the medical device and telecommunication
industries. His primary focus in MedTech is manufacturing equipment data
integration methodologies and it’s collection into enterprise systems. For the
last 4 years, James has played an integral part in forming and leading the site
digitalisation transformation strategy and has been a key contributor to the
corporate Digital Factory team.





Develop and evolve the site data architecture to build connection pipelines
which securely expose key manufacturing data to drive improved insights and
promote efficiencies


MIKE MURPHY

DIRECTOR OF SITE SERVICES & EQUIPMENT ENGINEERING - BOSTON SCIENTIFIC

"BOSTON SCIENTIFIC DIGITALISATION STRATEGY"

Speaker Bio Synopsis



Michael has 38 years experience in Manufacturing & Product Development in the
Med Tech, Telecoms and Computer Assembly sectors. For the last 12 years Michael
has expanded an Equipment Engineering organization who design and install smart
manufacturing technology solutions with the mission of delivering high quality
health care products globally. Michael has a B. Eng. (Mechanical), diploma in
accounting & finance, and Masters in Industrial Engineering.





Boston Scientific Galway will provide valuable insight into their Digital
transformation journey by sharing their vision of the future of Smart
Manufacturing at their campus. Sponsor and accelerate the effective deployment
and maturation of Digital Factory and automation capabilities throughout the
supply chain operations in the Boston Scientific Galway site.


DR TOBY SAINSBURY

DIRECTOR - FUTURE MANUFACTURING IRELAND UNIT, DEPARTMENT OF ENTERPRISE, TRADE
AND EMPLOYMENT.

"FUTURE MANUFACTURING IRELAND: NATIONAL COORDINATION OF ADVANCED MANUFACTURING
SUPPORTS"

Speaker Bio Synopsis



Experienced Technologist focused on strategic management of the National
Research & Development ecosystem to support Advanced Manufacturing/Industry 4.0
and digital technology adoption and deployment across the manufacturing sector.
Over twenty years’ experience encompassing technology planning, implementation
and project management experience within academic and government research groups
as well as in the chemical industry and nanotechnology start-up companies.
Extensive experience interfacing and liaising within the National R&D ecosystem,
Government Agencies and Departments, and with global technology companies as
part of joint technical collaboration, strategic funding initiatives, and client
relationships.

Toby has 17 years’ experience in R&D and management roles in academia,
government, and industry. Prior to joining IDA Ireland, he has worked within
start-up nanotechnology companies in the UK, Silicon Valley, and Saudi Arabia,
the chemical industry in Germany as well as working in and leading research
groups in National Laboratories in the US and UK.





Ireland’s National Strategy for Industry 4.0 was published in 2020 and set out a
clear and ambitious vision statement. Ireland’s vision is that by 2025 it will
be a competitive, innovation-driven, manufacturing hub at the frontier of the
Fourth Industrial Revolution and at the forefront of Industry 4.0 development
and adoption. Ireland intends to develop a global reputation for advanced
manufacturing arising from state-funded and industry co-funded research in the
country’s R&D Centres. To deliver this vision, The Department of Enterprise,
Trade and Employment (DETE) has established a new coordination mechanism –
‘Future Manufacturing Ireland (FMI), to ensure coherence and optimal delivery of
RD&I supports to the manufacturing sector. This will be achieved through the
coordination of resources across publicly funded centres with a dedicated focus
on Advanced manufacturing/Industry 4.0, as well as through the support
mechanisms from the Enterprise Agencies; IDA Ireland and Enterprise Ireland. FMI
will develop the breadth of capability required across publicly funded research
centres in a coherent and coordinated manner and to ensure that this capability
if promoted to firms of all sizes. This new coordination mechanism will ensure
maximum alignment of activities across the system, avoiding unnecessary
duplication and fragmentation of effort. Through a coherent spectrum of supports
the FMI mechanism will promote engagement between the network of Advanced
Manufacturing centres and the enterprise base. FMI will support the drive to
uptake and deploy digital technologies within the manufacturing sector and will
ensure its competitiveness and future viability. In this talk, the mission and
vision of FMI will be presented. The development of the unit and its remit will
be discussed in the context of supporting the manufacturing sector.


ALAN SLATTERY

SENIOR MANUFACTURING SYSTEMS MANAGER - BOSTON SCIENTIFIC

"DATA PIPELINES (VISUALISATION, ANALYSIS AND PREDICTABILITY)"

Speaker Bio Synopsis



Alan has a B Eng in Electronic Engineering and MSc in Software Engineering &
Database Technologies. Alan has 30 years of experience in Manufacturing IT in
the Med Tech, Telecoms and Computer Assembly sectors. For the last 8 years Alan
leads a team of software engineers, analysts and data scientists, leveraging
data from enterprise and manufacturing systems to derive insights and deliver
value for Boston Scientific.





Leveraging enterprise, equipment & process data to supply real time analytics &
data driven applications to the organization


JULIO ZANON

PRINCIPAL TECHNOLOGY ENGINEER - BOSTON SCIENTIFIC

"ENHANCING AUTOMATED PRODUCT INSPECTIONS THROUGH AI/ROBOTICS"

Speaker Bio Synopsis



Julio is currently completing a PhD in A.I. applied to visual inspections. Julio
has over 20 years of experience working in all areas of automation, across
multiple industries. For the last 4 years, Julio has focused on the development
and roll out of strategies to deploy the latest industry4.0 trends into Boston
Scientific’s manufacturing environments.





Developing Strategies and Capabilities to adapt and deploy new technologies into
manufacturing such as A.I. and Advance robotics


DAVID MCCORMACK

DIRECTOR OF SUSTAINABLE MANUFACTURING - IRISH MANUFACTURING RESEARCH (IMR)

"CIRCULAR VENTURES: DRIVERS & OPPORTUNITIES"

Speaker Bio Synopsis



David is the chair of the NSAI national mirror committee for ISO 323 –Circular
Economy and is also Program Director of CIRCULÉIRE- The national platform for
Circular Manufacturing which looks to transition industry in Ireland to a low
carbon circular economy by demystifying, derisking and delivering circularity
through system-level innovation. David leads and develops a sustainable
manufacturing research strategy, oversees research grants programs, and
evaluates research program effectiveness and impact to deliver outcomes which
can be applied for the benefit of industry/consumers/customers. He establishes
and maintains productive working relationships and networks with stakeholders,
public and private sector funding bodies, and state agencies, fostering research
partnerships across organisational programs and projects to capitalise on
funding and resource opportunities.





CirTex, IFF Plastics and Niskus Biotec will share their journey to scaling up
their circular ventures. CIRCULÉIRE will also announce its 2022 Circular Venture
Cohort. Moderated by David McCormack, Director of Sustainable Manufacturing at
Irish Manufacturing Research (IMR)


BRENDAN MCGRATH

SITE HEAD AND VICE PRESIDENT OF MANUFACTURING - WUXI BIOLOGICS

"WUXI BIOLOGICS IRELAND"

Speaker Bio



As Ireland Site Head and Vice President of Manufacturing at WuXi Biologics, Mr.
Brendan McGrath is a well-recognized technical and managerial leader with more
than 25 years of industrial and pharmaceutical manufacturing experience. Since
joining WuXi Biologics in 2018, he has led its branch in Ireland, where the
company plans to build a “factory of the future” and add 54,000 liters of
capacity to the WuXi Biologics network. When completed in 2021, it will be the
largest single-use facility in the world and will supply biologics products to
the United States and other global destinations. Mr. McGrath is a board member
of WuXi Biologics Ireland Ltd and WuXi Vaccines Ireland Ltd.

Before joining WuXi Biologics, Mr. McGrath worked in various senior leadership
positions including Plant Manager, Supply Chain Director and Operational
Excellence Director for MSD, Schering Plough and Organon.

Mr. McGrath earned his bachelor’s degree in industrial engineering from the
National University of Galway.


MARC O'REGAN

TECHNOLOGIST & CTO EMEA - DELL TECHNOLOGIES

"ARCHITECTING BEHIND THE SCIENCE OF A DISTRIBUTED ECOSYSTEM"

Speaker Bio Synopsis



Marc is a passionate believer in Technology and how we can work together as an
industry to better enhance and empower every person and organization in the
world to achieve more. Marc is the CTO for Dell Technologies EMEA & has over 20
years’ experience in Technology, starting his career at Dell Technologies in
1999 where he spent sixteen and a half years specializing in various Technology
domains including Cloud, Data Analytics and High Performance Computing. During
his career at Dell Technologies Marc successfully lead the Cloud and Compute
Specialist Practice for Dell UK & Ireland, helping to architect, design and
develop compute and Cloud solutions, while also leading the Enterprise Architect
community for EMEA. Marc has also notably contributed significantly to Public
Cloud build outs including Microsoft Azure and Amazon Web Services as well as
some of the most significant HPC and Supercomputing Clusters on the continent of
Europe. Marc is also a recognized leader within the Cloud and Grid communities
and is a regular keynote speaker and contributor of articles on the subjects of
Cloud, Modern Analytics, IoT and HPC. As CTO for the Dell Technologies EMEA
organization, Marc leads the vision and cross company technology strategy across
the EMEA Theatre with a focus on driving innovation working predominantly with
New & Emerging Technologies and architecture in the AI, Analytics, HPC and IoT
space. During his home time, Marc enjoys Arts, reading, hill walking with his
Dog Rugby and the odd Motor race. Marc is a graduate of Trinity College Dublin
and lives with his wife and two girls in Wicklow, Ireland.





Industrial Internet of Things motions to the extension and use of IoT in
industrial sectors and applications. With a strong focus on machine-to-machine
(M2M) communication, big data, and machine learning, the IIoT enables industries
and enterprises to have better efficiency and reliability in their operations.
At Dell Technologies we define the Edge as wherever the physical world and the
digital world intersect, where data is generated, collected, and processed to
create new value. Emerging trends will disrupt entire industries and as we
democratize Technology and advances in silicon enable higher performance and
lower power draw from smaller form-factors, more functionalities that were
traditionally tied to wire or a central location is now decentralized and
wireless and driven by Data. This requires collaboration, consistency in service
and standards, collection, normalization visualization and analysis of Data and
all in a chaotic ecosystem that is natively disaggregated and disconnected.
Connectivity and integration are the steppingstones to powering new services
through new apps at the edge and driving these functions through the collection
of intelligence in near real time. The direction of cloud is Native, and its
destination is Edge – We are now preparing for Edge Native capabilities, to take
something new and modern and connect it to something archaic and proprietary.
During this session, Marc will talk to Modern Analytics, Functions of Artificial
Intelligence and the Management, flow and analysis of Data as it moves through
the ecosystem and the architecture and the infrastructure and application layers
appropriate to Modern Analytics and information extraction


SÉAMUS CLANCY

CHIEF EXECUTIVE OFFICER - REPAK

"IS IT BUSINESS AS USUAL OR DO WE ALL AS BUSINESS LEADERS HAVE TO RECALIBRATE
OUR THINKING ON WHAT A SUSTAINABLE BUSINESS WILL LOOK LIKE IN THE FUTURE."

Speaker Bio



Séamus Clancy joined Repak Ltd as Chief Executive in April 2014, with over 20
years’ industry experience as a senior executive.
A native of Cork, Séamus holds a primary degree in Civil Engineering from UCC
and a master’s from the University of Birmingham, UK. Prior to Repak, Séamus was
Chief Operating Officer of Environmental Group One51plc., and also held the role
of Managing Director of Rilta Environmental Limited and Director of Enterprise
at the Rehab Group.
Since joining Repak, Seamus has transformed the organisation, growing Membership
by over 50% and establishing Repak as a leading environmental organisation and
educator on packaging recycling and best practice recycling in Ireland.
In 2015, Séamus oversaw the development of Ireland’s new End of Life Tyre
compliance scheme, Repak ELT, which recycled 3.8m tyres in 2018, and is now a
successful stand-alone organisation effectively managing tyre waste using
environmentally responsible solutions, and reducing pollution
More recently, Séamus has led the development of a number of new environmental
initiatives including the Repak Plastic Packaging Recycling Strategy 2018-2030,
the highly successful Repak Members’ Plastic Pledge and the ‘Repak Team Green’
campaign, aimed at encouraging the Irish public to protect the environment, and
to reduce, reuse and recycle more and better.


BARRY CURRY

DIRECTOR AND PRINCIPAL CONSULTANT - SYSTEM E

"THE IMPACT OF DIGITAL IN LIFE SCIENCES MANUFACTURING"

Speaker Bio Synopsis



A Project Management and Manufacturing Systems consultant with over 20 years’
experience in managing complex software projects for some of the world’s largest
Life Sciences manufacturers. Barry has a long track record of delivering on
complex projects and for rescuing and reviving failing projects internationally.





Digital Transformation is not just about technology, it's about how technology
can impact your business. This presentation will focus on the how to plan in
advance for the impact of digital and how you can prepare your people, processes
and the business for successful adoption of new technology..


GUGLIELMO IOZZIA

ASSOCIATE DIRECTOR - BUSINESS TECH ANALYSIS, IT AND ANALYTICS - MSD

"NOT ONLY DEEP FAKES: DEEP LEARNING GENERATIVE MODELS APPLICATIONS IN PHARMA
MANUFACTURING"

Speaker Bio Synopsis



Guglielmo Iozzia is currently working at MSD, where he is a member of the Merck
Manufacturing Division - IT. He is based in Ireland but involved in projects
overseas as well. At MSD he is busy leading, executing and delivering ML/AI
projects (with focus mostly in Computer Vision, but not restricted to this field
anyway) and make sure they generate the expected business value. His journey
into Data and ML/AI started more than 8 years ago at IBM and continued at Optum
(UnitedHealth Group) before joining MSD in early 2019. He is also an
international speaker since 2018: he gave talks about Deep Learning and Computer
Vision to more than 40 events, including one edition of the Spark+AI Summit, the
Open Data Science Conference, 2 editions of the Big Things Conference, DataWorks
Summit and the National Manufacturing and Supply Chain Conference for Ireland
and UK.





Deep Generative Models are sadly used for Deep Fakes, but that's not the only
field of application for such models. There are many other real-life use cases
for good in diverse industries. These tasks come with challenges, but there is a
great business potential for this family of deep neural networks that just
started to be discovered. This talk will walk through a real-life application of
Deep Generative Models in pharma manufacturing.


MATT MORAN

DIRECTOR - BIOPHARMACHEM IRELAND

"BIOPHARMA MANUFACTURING SECTOR IN IRELAND – FUTURE CHALLENGES"

Speaker Bio



Matthew Moran is Director of BioPharmaChem Ireland. He graduated in Chemistry at
Trinity College Dublin in 1980 and in Chemical Engineering at University College
Dublin in 1981; he holds an MBA also from University College Dublin (Smurfit
School of Business). He worked for over ten years in the pharmaceutical industry
where he held a number of management positions both in active ingredient and
dosage form manufacture. He is a member the European Chemical Industry Council
(CEFIC). Matthew Moran is a Board member of the Active Pharmaceuticals
Ingredients (API) Committee of CEFIC (CEFIC/APIC) and The European Association
for Bioindustries (Europabio) BioPharmaChem Ireland represents the interests of
the biopharmachem sector in Ireland. CEFIC/APIC represents the European API
Industry. Europabio represents the European Biotech Sector.


GERARD CARTON

MANAGING DIRECTOR - PLANTQUEST

"DIGITISING THE BROWNFIELD"

Speaker Bio Synopsis



Ger Carton is the co-founder and CEO of PlantQuest, a software company enabling
pharmaceutical and other large process facilities to digitally transform their
asset management operations with intelligent mapping. Prior to this, Ger has
gained two decades of experience within the industry working across a range of
disciplines globally.





No stranger to the challenges and opportunities involved in introducing
digitisation to the brownfield, Ger shares his learnings and experiences in the
matter. Ger will cover the topics of expectations vs reality, the challenges &
opportunities, solutions & tools, the brownfield landscape (a market
perspective), and bite-sized BIM.


MIKE J. HAYES

ENGINEERING TECHNOLOGIST - DELL TECHNOLOGIES

"INNOVATION AT THE MANUFACTURING EDGE WITH DELL TECHNOLOGIES"

Speaker Bio



Mike J. Hayes is an Engineering Technologist within the Dell Technologies Edge
Solutions team. The primary focus of Mike’s current role is technical marketing
and customer engagement related to edge, digital twins and manufacturing,
including partnerships and technical enablement. Mike is also responsible for
technical engagement with global key customer accounts and for developing
solutions specific to these customers. Mike’s background is in enterprise IT,
with 25 years’ experience working in IT and global technical presales. Mike is
based out of Limerick, Ireland.


LUKE MIDDLETON

HEAD OF TECHNOLOGY & INNOVATION - DATADYNE CONSULTING

"WHAT IS PHARMATECH?"

Speaker Bio Synopsis



Luke co-founded and is Head of Technology & Innovation at DataDyne Consulting,
currently operating in Ireland, South America, Asia and the USA. Luke's
involvement in the medtech industry is often focussed on digitalisation of
processes and companies themselves. With an MSc in Health Informatics from TCD,
Luke has established himself as a high level medical IT consultant.





Technology has changed how the pharmaceutical industry operates. Pharma and
biotech companies can develop life changing treatments quicker and cheaper,
often with a higher success rate. This coupled with constant advances in
electronic prescription technologies, creates a higher patient success rate.


BARRY PROST

MANAGING PARTNER - YALA

"STRATEGIES TO SUCCESSFULLY FILL ‘HARD-TO-FILL’ ROLES IN THE PHARMACEUTICAL &
LIFE SCIENCES SECTOR."

Speaker Bio Synopsis



Barry Prost has 20 years experience in international recruitment and has co
founded award winning brands in the sector including Propel Consult and Yala.
Barry has a degree in Business from Trinity College Dublin and MBA from the
Smurfit School of Business. Barry is a Committee Member of the Employment &
Recruitment Federation and also serves on the board for the SFA overseeing the
MentorsWork initiative.





In this talk, we outline the challenging roles companies are currently
struggling to fill and provide insights and tips into how to successfully
resource these vacancies.


JUFAN ZHANG

ASSISTANT PROFESSOR/LECTURER - UCD CENTRE OF MICRO / NANO MANUFACTURING
TECHNOLOGY

"3D STRUCTURED HOLLOW MICRONEEDLES AND DISSOLVING MICRONEEDLES"

Speaker Bio Synopsis



Dr Jufan Zhang is the Assistant Professor of UCD, working on the design and
manufacturing of innovative medical devices and bioimplants. He has developed
featured microneedle devices, including 3D structured polymer hollow microneedle
array, solid metal microneedles, dissolving microneedles with modified HA to
control the ingredient release speed.





Microneedle is a user-friendly solution for transdermal delivery of medicament
or cosmetic ingredient, thus has the promising prospect for a variety of
applications. Two major bottlenecks identified in this market sector are the
applicable drug dosage and cost-effective manufacturing process chain. New
designs and manufacturing solutions are proposed by UCD researchers to make
significant progress addressing these challenges.


JOHN BEHAN

HEAD OF SCHOOL OF SCIENCE AND COMPUTING - TU DUBLIN

"LABORATORY APPRENTICESHIPS - 'EARN AS YOU LEARN'"

Speaker Bio Synopsis



John Behan Graduated from NUIG with an Honours Degree in Microbiology. He
completed a Masters by Research in Industrial Microbiology at UCD. After
Graduation, he was recruited to work in the Dublin facility of the Dutch
Multinational Healthcare Company Organon Teknika Ltd., initially as Project
Scientist, and subsequently was promoted to Head of their Diagnostic
Manufacturing Division. His roles included Technology Transfer and
responsibility for the overall running of the Department. During this time, he
completed the Masters in Business Studies - Manufacturing Management on a part
time basis in the world renowned Smurfit Business School in UCD Graduating with
Honours.

After 5 years in industry, he joined the lecturing staff of the Institute of
Technology Tallaght, Science Department, where his responsibilities included
industrial liaison, delivery and co-ordination of fulltime and part time
programs. In 2007 he was promoted to Head of the Department of Applied Science
in the Institute of Technology Tallaght, now the Technological University
Dublin, Tallaght Campus. Key roles include overall responsibility for the
delivery of full and part time programs, industry training, International
Program delivery and Research. In 2019, he was appointed as an Honorary
Associated Professor by Nanjing Tech University, Nanjing China as recognition of
his leadership role in the delivery of a joint pharmaceutical education
programme between the two universities. In early 2021 he was appointed to the
role of Head of School of Science and Computing in TU Dublin, Tallaght Campus
joining its Senior Management Team. Key recent activities include playing a
leadership role in the ongoing transition phase of the organisational design of
TU Dublin.





The laboratory apprenticeships have been designed by industry, for industry.
They are closely aligned with the current needs of the BioPharamChem sector as
well as the Medical Devices and Diagnostics, Food and Drink and Independent
Testing Laboratory sectors. TU Dublin is the lead academic provider.


TIM COMMANE

DIRECTOR OF LIFE SCIENCE - IPP GROUP

"REGULATORY GUIDANCE ON THE LIFE CYCLE APPROACH TO CONTAINER CLOSURE INTEGRITY
TESTING"

Speaker Bio Synopsis



Tim Commane is the Director of Life Science at IPP Group and has worked in the
pharmaceutical and medical device industries for over 15years. Tim has worked
with many of the industry's largest manufacturers to help identify, develop and
qualify solutions for package inspection. Tim hosts regular seminars at the IPP
Group workshops where we create opportunities for learning and discussion
amongst stakeholders and global experts on topics such as testing,
serialisation, regulatory compliance and automation.





This presentation will look at the path of regulatory guidance over the last
decade, in the context of container closure integrity inspection for
pharmaceutical product packaging and help explain what this means across the
manufacturing life-cycle. We will cover why different approaches and
justifications need to be considered for different stages of product development
and manufacture and look at emerging technologies and where they fit across
these various stages. - Overview of regulatory guidance for CCIT -
interpretation of the guidance - understanding the approach to choosing and
justifying which method to apply to your product - Overview of new technologies


DR ADRIENNE FLEMING

SENIOR LECTURER, COORDINATOR OF THE NATIONAL PHARMACEUTICAL CENTRE - TU DUBLIN

"LIFELONG LEARNING AND UPSKILLING OPPORTUNITIES - TRAINING AND EDUCATION
PROGRAMMES - NATIONAL PHARMACEUTICAL EDUCATION CENTRE, TU DUBLIN"

Speaker Bio Synopsis



Dr. Adrienne Fleming is a Senior Lecturer in Science in the School of Science
and Computing at the Technological University Dublin. Dr. Fleming is a chemistry
graduate of NUI Galway with a PhD in Organic Chemistry also from NUI Galway. Dr.
Fleming is the coordinator of the National Pharmaceutical Education Centre in
the University. Adrienne works closely with many of the leading pharmaceutical
and biopharmaceutical companies on development, design and delivery of education
programs. Adrienne is an active member of a number of professional bodies
including the ISPE and RSC.





Talk synopsis: (i) Working with Industry to respond to emerging skills needs of
enterprise (ii) Providing lifelong learning and upskilling opportunities


SIVE GEOGHEGAN

MANAGER - ENTERPRISE IRELAND TECHNOLOGY GATEWAY MICRA

"ENGAGING WITH THE TU DUBLIN MICRA GATEWAY AND SUPPORTS AVAILABLE TO SMES - CASE
STUDY: BRAND INTEGRITY AND CHEMOMETRICS"

Speaker Bio Synopsis



Enterprise Ireland funded Technology Gateway Manager at TU Dublin MiCRA Gateway.
Strategic, pro-active and results driven with a successful small and large-scale
R&D projects, markets and sales growth. Responsible for the development and
execution of long-term strategies with the aim of increasing shareholder and
stakeholder value. Skilled communicator. Strong at driving collaboration between
multiple stakeholders and working at the interface between both Business to
Business and Industrial-University engagements.





Looking at how companies can successfully engage with TU Dublin expertise,
funding options available and paths for success. Using a sample case study MiCRA
worked on based on Brand Protection of Irish Whiskeys.


EAMON JUDGE

SENIOR DIRECTOR, GLOBAL ENGINEERING - ELI LILLY

"LILLY KINSALE - DELIVERING ON THE PROMISE OF POWER FROM THE SUN."

Speaker Bio Synopsis



Eamon Judge graduated from University College Dublin with a Bachelor’s degree
(Honours) in Chemical Engineering and joined Eli Lilly, Kinsale, Cork , Ireland
in 1980.
In the 1980s he held various management roles at the site and during the mid
1990s, Eamon relocated to Eli Lilly’s Corporate Headquarters in Indianapolis, US
and held several leadership roles in Corporate Strategic Facilities Planning and
Technology & Facilities Design. He completed an EMBD at Purdue University
Krannert School of Management during this period.
In the late 90s , Eamon returned to Ireland and became a Site Senior Leadership
Team member as Director of Antibiotic API Production Operations. In the
subsequent decade he has held Director level positions in Aseptic Manufacturing
, HSE , Manufacturing IT and Automation, Supply Chain Operations and
Engineering.
In 2016 Eamon moved to an EMEA Project leadership role working for the Global
Engineering function and was subsequently responsible for strategic planning for
over $1b of capital investments in Europe and Asia.
He is currently a Senior Director in Lilly’s Global Engineering Function with
global facilities management responsibilities.
He has a personal in sustainability and led the development of what is currently
Ireland’s largest solar farm : a 26 acre development that supplies Lilly’s
Kinsale Manufacturing site with over 8 GWH of power annually equivalent to the
carbon sequestration of over 7,000 acres of forestry
Eamon represented Eli Lilly for many years on the Council of BioPharmaChem
Ireland, the industry association representing the biopharma sector in Ireland.
Up to 2021 he was President of the Ireland Affiliate of the International
Society for Pharmaceutical Engineering (ISPE) and led the lifesciences COVID
Alliance which brought together over 50 organisations to support the HSE and
state in responding to Covid. He has been recognised by peers around the world
by being awarded the Global Volunteer of the Year award by ISPE in 2020 and in
2021 was d





This presentation will track the history of Eli Lilly’s Kinsale manufacturing
facility as it has expanded over the past 4 decades and followed a
sustainability journey culminating in the recent development of 26 acres of
solar generation capacity . This largest ‘behind the meter’ solar development in
Ireland is intended as a flag ship example of a mid-scale system which could
easily be emulated by other organisations and delivers an annual carbon
reduction equivalent to the sequestration of over 7,000 acres of forestry. This
capital investment is one of the site’s key decarbonisation steps as Lilly
intends becoming globally carbon neutral by 2030.


DR BEN RYAN

SENIOR LECTURER - RCSI

"BSC (ADVANCED THERAPEUTIC TECHNOLOGIES) - DEVELOPING WORKPLACE READY SCIENCE
INNOVATORS"

Speaker Bio Synopsis



Dr Ben Ryan is Senior Lecturer in Pharmacology in the School of Pharmacy and
Biomolecular Sciences at RCSI and also Head of the Neuropsychoendocrinology
Research Group. In 2021 he was appointed as Programme Director of the BSc
(Advanced Therapeutic Technologies) degree programme which will intake its first
students in September 2022. His research interests focus on depression with a
particular emphasis on how endocrinological dysfunction may contribute to
treatment resistant depression. In addition, Dr Ryan has published in the areas
of cancer and recurrent infection with an emphasis on novel drug delivery
systems/therapeutic strategies. Dr Ryan is a Pharmacy graduate of RCSI-
University of Medicine and Health Sciences, and also holds a PhD
(Neuropharmacology) and BA(Mod) Biochemistry from Trinity College Dublin.





The (bio) pharmaceutical and health sector is facing a new era of opportunity as
it incorporates healthcare innovations and technologies in areas such as
genomics, precision medicines, big data and connected health. With issues of
sustainability, an aging population and increasing levels of non-communicable
diseases, the rapid acceleration of healthcare-related knowledge which fuses
digital technologies with traditional science offers the potential for radical
sectoral transformation and enhanced patient outcomes. This has led to an
increasing focus on disease prevention and tailored therapies and technologies.
Given this, there is a need to reimagine university science education to develop
the next generation of scientists capable of innovating and collaborating to
deliver novel and transformative therapeutic technologies. The RCSI BSc in
Advanced Therapeutic Technologies has been designed specifically to equip
students with extensive, future-focused scientific knowledge and technical
skills in addition to transversal competencies to address current and future
global healthcare needs. This project has been supported by the Higher Education
Authority under the Human Capital Initiative, Pillar 3. Grant agreement:
17796884 ‘Enabling Future Pharma’.


PAUL WALSH

GENERAL MANAGER - EMEA

"BMS ALARM FATIGUE - THE RISKS, AND REWARDS THAT CAN BE DELIVERED WITH DATA"

Speaker Bio Synopsis



Leading CIM’s European expansion, Paul joined CIM with a passion for combating
climate change and how disruptive technology has the ability to remove barriers
to delivering demand-side energy savings for large property owners in a very
short time frame. With 20 years of industry experience in delivering energy
savings, Paul is a Certified Energy Manager with a Bachelor of Technology (Hons)
in Manufacturing Technology & an MBA from the University of Limerick.





“Without accurate, reliable & relevant information from a vast dataset, you
cannot make intelligent decisions about energy consumption, benchmarking &
sustainability in manufacturing facilities around HVAC & Utilities.” - Conor
Murray, President, ASHREA Ireland A recent survey conducted by CIM found 34% of
high tech facilities managers to confirm that HVAC is their sites biggest energy
cost. It was also reported that FM teams are overwhelmed with data and BMS
alarms, - on average a BMS delivers 12.5 alarms every day, with 50% of sites
reporting as many as 30 and 27% of respondents admitting to ignoring all BMS
alarms. This alarm fatigue leads to inaction, and in CIM’s experience, this
leads to critical optimisation opportunities being missed. Overall, alarms are
generally not regarded as an aid to better control of a HVAC system or as a
means for an organisation to mitigate its energy costs or reduce its CO2
emissions. Rather, alarms are being regarded as a nuisance that can be ignored,
ultimately demonstrating that there is insufficient value being delivered by the
BMS or the data. Are you suffering from BMS alarm fatigue? Are you struggling to
know where to start? Join us as we chat through: -Key results from the research
-How to avoid BMS Alarm fatigue -A Guide to HVAC Efficiency -Case Study examples
of PEAK Success


CLIVE HICKMAN

CHIEF EXECUTIVE - MANUFACTURING TECHNOLOGY CENTRE

"BUILDING RESILIENCE THROUGH INNOVATION"

Speaker Bio



Clive Hickman was born in Dudley, West Midlands, and studied at the University
of Wolverhampton, Aston University and Loughborough University, holding a BSc,
PhD in mechanical engineering and a MBA.
During his career, he has been Chief Executive of Tata Motors European Technical
Centre, Managing Director of Ricardo UK, Engineering Director at MIRA and
Executive Engineer with Rover Group.
Clive has been CEO of the MTC since it was founded in 2010. He chaired the
Midlands Manufacturing Resilience Commission and won the Institute of Directors
Chair’s Award for Excellence and Board Practice for the West Midlands in 2020.
On the international stage, Clive now represents the UK Research Technology
Organisation community on the Board of the European Association of RTOs.
Clive recently received one of the Royal Academy of Engineering's most
prestigious awards - the Sir Frank Whittle Medal and was awarded an OBE in this
year’s Queen’s honours.




CO-LOCATED EVENTS



SPONSORS

 
 
 
 

PARTNERS



CONTACT
 * Home
 * Register
 * Contact

Type and Press “enter” to Search